glp-1 in pregnancy GLP1-RAs: The New Era of Diabetes and Weight Loss Management, FAQs and Lactation JCI Insight - Maternal antagonism
Description
Similar content being viewed by others Background The injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used in the management of type 2 diabetes mellitus (T2DM) [1]
According to FDA guidelines, these medications are approved for people with a: A body mass index (BMI) of 30 or higher BMI of 27 or higher who have at least one weight-related health condition, like type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease These criteria help ensure that those most likely to benefit from treatment are prioritized
Trends Cogn Sci (2011) 15(1):3746.10.1016/j.tics.2010.11.001 102 WangGJVolkowNDLoganJPappasNRWongCTZhuWet alBrain dopamine and obesity
For individuals with diabetes, these effects can improve glycemic control and reduce cardiovascular risk
